http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8709710-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ae2fbbd95296ad63c505160cc9be30f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9041b43ff34f7e21d151bb84bbcec12c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aacbbcb8667b06fcf2681b7862605f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0b29417a1039124b654e66188501f60
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6324869259b5797f8d26d01342e8abdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d7d7fad7ca858d9b558cd383ba1ac4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98204cb3c46305b3fefab8f7df590f81
publicationDate 2014-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8709710-B2
titleOfInvention Methods of modulating interleukin-22 and immune response by notch regulators
abstract The invention relates to the use of notch regulators for modulating IL-22 production in T-cells, by influencing the activity or activation of the notch signal path. The invention further relates to the use of modulating the immune response, primarily in case of infection reactions. The invention in particular relates to the use for treating illnesses associated with infections. The invention further relates to the use for reducing IL-22 production in T-cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944700-B2
priorityDate 2009-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887475-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010136022-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003194804-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008092445-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9820142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096952-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400643

Total number of triples: 40.